Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Soleus Investor Activism is Strategic for Multiple Reasons

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Dec 01, 2023 7:50am

112 Views

Post# 35762898

RE:RE:Soleus Investor Activism is Strategic for Multiple Reasons

This is the last tme we get to have a say in this company. Soleus can count on me in their push for change or sale of the company. Whatever they jusdge is the best at this point. I have zero trust in the BOD and C-Suite. None,

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals